Clovis Oncology, Inc.

GABELLI FUNDS LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

110,900

Value ($000)

132

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	132	0.0%	110,900	9/30/2022
2022 Q2	8/12/2022	203	0.0%	112,900	6/30/2022
2022 Q1	5/18/2022	232	0.0%	114,900	3/31/2022
2021 Q4	2/11/2022	298	0.0%	109,900	12/31/2021
2021 Q3	11/12/2021	490	0.0%	109,900	9/30/2021
2021 Q2	8/13/2021	608	0.0%	104,900	6/30/2021
2021 Q1	5/14/2021	701	0.0%	99,900	3/31/2021
2020 Q4	2/5/2021	744	0.0%	155,100	12/31/2020
2020 Q3	11/6/2020	886	0.0%	151,900	9/30/2020
2020 Q2	8/13/2020	988	0.0%	146,400	6/30/2020
2020 Q1	5/14/2020	950	0.0%	149,400	3/31/2020
2019 Q4	2/14/2020	1,547	0.0%	148,400	12/31/2019